Gamma-linolenic acid in borage oil reverses epidermal hyperproliferation in guinea pigs.
As dietary sources of gamma-linolenic acid [GLA; 18:3(n-6)], borage oil (BO; 24-25 g/100 g GLA) and evening primrose oil (PO; 8-10 g/100 g GLA) are efficacious in treating skin disorders. The triglycerol stereospecificity of these oils is distinct, with GLA being concentrated in the sn-2 position of BO and in the sn-3 position of PO. To determine whether the absolute level and/or the triglycerol stereospecificity of GLA in oils affect biological efficacy, epidermal hyperproliferation was induced in guinea pigs by a hydrogenated coconut oil (HCO) diet for 8 wk. Subsequently, guinea pigs were fed diets of PO, BO or a mixture of BO and safflower oil (SO) for 2 wk. The mixture of BO and SO (BS) diet had a similar level of GLA as PO but with sn-2 stereospecificity. As controls, two groups were fed SO and HCO for 10 wk. Epidermal hyperproliferation was reversed by all three oils in the order of BO > BS > PO. However, proliferation scores of group PO were higher than of the normal control group, SO. The accumulations of dihomo-gamma-linolenic acid [DGLA; 20:3(n-6)], an elongase product of GLA, into phospholipids and ceramides, of 15-hydroxyeicosatrienoic acid (15-HETrE), the potent antiproliferative metabolite of DGLA, and of ceramides, the major lipid maintaining epidermal barrier, in the epidermis of group BO were greater than of groups BS and PO. Group BS had higher levels of DGLA, 15-HETrE and ceramides than group PO. With primary dependence on absolute levels, our data demonstrate that the antiproliferative efficacy of GLA in the epidermis is preferably exerted from sn-2 stereospecificity of GLA in BO.
D000052:Acanthosis Nigricans / Q000139:chemically induced; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002518:Ceramides / Q000096:biosynthesis; D003879:Dermatologic Agents / Q000737:chemistry* / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004817:Epidermis / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology; D005227:Fatty Acids / Q000032:analysis; D005228:Fatty Acids, Essential / Q000737:chemistry / Q000627:therapeutic use; D006168:Guinea Pigs; D006965:Hyperplasia / Q000139:chemically induced; D008041:Linoleic Acids; D008297:Male; D031665:Oenothera biennis; D010938:Plant Oils / Q000737:chemistry / Q000627:therapeutic use; D012450:Safflower Oil; D012867:Skin / Q000187:drug effects / Q000473:pathology; D012871:Skin Diseases / Q000188:drug therapy*; D013237:Stereoisomerism; D016896:Treatment Outcome; D017965:gamma-Linolenic Acid / Q000737:chemistry* / Q000627:therapeutic use*
D002518:Ceramides; D003879:Dermatologic Agents; D005227:Fatty Acids; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D010938:Plant Oils; C028498:evening primrose oil; D017965:gamma-Linolenic Acid; D012450:Safflower Oil; C079363:borage oil